Literature DB >> 22237749

Role of microRNAs in kidney homeostasis and disease.

Karthikeyan Chandrasekaran1, Dwi S Karolina, Sugunavathi Sepramaniam, Arunmozhiarasi Armugam, E Marelyn Wintour, John F Bertram, Kandiah Jeyaseelan.   

Abstract

MicroRNAs (miRNAs) are endogenous short (20-22 nucleotides) non-coding RNA molecules that mediate gene expression. This is an important regulatory mechanism to modulate fundamental cellular processes such as differentiation, proliferation, death, metabolism, and pathophysiology of many diseases. The miRNA expression profile of the kidney differs greatly from that of other organs, as well as between the different regions in the kidney. In kidneys, miRNAs are indispensable for development and homeostasis. In this review, we explore the involvement of miRNAs in the regulation of blood pressure, hormone, water, and ion balance pertaining to kidney homeostasis. We also highlight their importance in renal pathophysiology, such as in polycystic disease, diabetic nephropathy, nephrogenic diabetes insipidus, hypertension, renal cancer, and kidney fibrosis (epithelial-mesenchymal transition). In addition, we highlight the need for further investigations on miRNA-based studies in the development of diagnostic, prognostic, and therapeutic tools for renal diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237749     DOI: 10.1038/ki.2011.448

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  80 in total

Review 1.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

2.  Functional miR143/145 Cluster Variants and Haplotypes Are Associated with Chronic Kidney Disease: a Preliminary Case-Control Study and Computational Analyses.

Authors:  Saman Sargazi; Milad Heidari Nia; Fariba Mirani Sargazi; Roghayeh Sheervalilou; Ramin Saravani; Sara Bahrami; Shekoufeh Mirinejad; Ali Alidadi
Journal:  Appl Biochem Biotechnol       Date:  2021-01-23       Impact factor: 2.926

Review 3.  MicroRNAs and the regulation of aldosterone signaling in the kidney.

Authors:  Michael B Butterworth
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-11       Impact factor: 4.249

Review 4.  microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

Authors:  Christian Schulte; Tanja Zeller
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

5.  Overview of polycystic kidney disease in children.

Authors:  Michel Baum
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 6.  Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules.

Authors:  Rosalinde Masereeuw; Frans G M Russel
Journal:  AAPS J       Date:  2012-09-08       Impact factor: 4.009

Review 7.  MicroRNAs in IgA nephropathy.

Authors:  Cheuk-Chun Szeto; Philip K-T Li
Journal:  Nat Rev Nephrol       Date:  2014-04-08       Impact factor: 28.314

8.  MicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion Injury.

Authors:  Kirti Bhatt; Qingqing Wei; Navjotsingh Pabla; Guie Dong; Qing-Sheng Mi; Mingyu Liang; Changlin Mei; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 10.121

9.  Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats.

Authors:  Camila S Silva; Ching-Wei Chang; Denita Williams; Patricia Porter-Gill; Gonçalo Gamboa da Costa; Luísa Camacho
Journal:  Food Chem Toxicol       Date:  2016-09-09       Impact factor: 6.023

10.  Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN).

Authors:  Kang Cheng; Partab Rai; Andrei Plagov; Xiqian Lan; Peter W Mathieson; Moin A Saleem; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2013-04-21       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.